Global Vaccines Digital Biomanufacturing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI08251284

Publication Date:

August 4, 2025

Pages:

127

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

According to this study, the global Vaccines Digital Biomanufacturing market size will reach US$ 1000 million by 2031.
Vaccines digital biomanufacturing refers to the integration of digital technologies (such as artificial intelligence, big data analytics, IoT, and modeling software) with biomanufacturing processes for vaccine production. It involves using digital tools to optimize each stage鈥攆rom vaccine design and cell line development to fermentation, purification, and quality control鈥攅nabling real-time monitoring, predictive maintenance, and automated adjustment of production parameters. This approach enhances manufacturing efficiency, reduces costs, shortens production cycles, and improves scalability, particularly for rapid response to emerging pathogens or pandemic scenarios.
United States market for Vaccines Digital Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Vaccines Digital Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Vaccines Digital Biomanufacturing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Vaccines Digital Biomanufacturing players cover Cytiva (Danaher Corporation), Eppendorf SE, Sartorius AG, Merck KGaA, Aspen Technology Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淰accines Digital Biomanufacturing Industry Forecast鈥� looks at past sales and reviews total world Vaccines Digital Biomanufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccines Digital Biomanufacturing sales for 2025 through 2031. With Vaccines Digital Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines Digital Biomanufacturing industry.
This Insight Report provides a comprehensive analysis of the global Vaccines Digital Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccines Digital Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Vaccines Digital Biomanufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines Digital Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines Digital Biomanufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines Digital Biomanufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Manufacturing Execution System (MES)
Process Analytical Technology (PAT)
Data Analytics Software
Digital Twins
Segmentation by Application:
Biopharmaceutical Companies
Contract Manufacturing Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cytiva (Danaher Corporation)
Eppendorf SE
Sartorius AG
Merck KGaA
Aspen Technology Inc
K枚rber AG
AmpleLogic
Siemens
Thermo Fisher Scientific Inc.
ABB
Bruker
Hamilton Company
Dassault Syst猫mes
Kymanox Corporation
Invert, Inc.
Genedata AG

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccines Digital Biomanufacturing Market Size (2020-2031)
2.1.2 Vaccines Digital Biomanufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Vaccines Digital Biomanufacturing by Country/Region (2020, 2024 & 2031)
2.2 Vaccines Digital Biomanufacturing Segment by Type
2.2.1 Manufacturing Execution System (MES)
2.2.2 Process Analytical Technology (PAT)
2.2.3 Data Analytics Software
2.2.4 Digital Twins
2.3 Vaccines Digital Biomanufacturing Market Size by Type
2.3.1 Vaccines Digital Biomanufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Vaccines Digital Biomanufacturing Market Size Market Share by Type (2020-2025)
2.4 Vaccines Digital Biomanufacturing Segment by Application
2.4.1 Biopharmaceutical Companies
2.4.2 Contract Manufacturing Organizations
2.4.3 Others
2.5 Vaccines Digital Biomanufacturing Market Size by Application
2.5.1 Vaccines Digital Biomanufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Vaccines Digital Biomanufacturing Market Size Market Share by Application (2020-2025)
3 Vaccines Digital Biomanufacturing Market Size by Player
3.1 Vaccines Digital Biomanufacturing Market Size Market Share by Player
3.1.1 Global Vaccines Digital Biomanufacturing Revenue by Player (2020-2025)
3.1.2 Global Vaccines Digital Biomanufacturing Revenue Market Share by Player (2020-2025)
3.2 Global Vaccines Digital Biomanufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vaccines Digital Biomanufacturing by Region
4.1 Vaccines Digital Biomanufacturing Market Size by Region (2020-2025)
4.2 Global Vaccines Digital Biomanufacturing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)
4.4 APAC Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)
4.5 Europe Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)
4.6 Middle East & Africa Vaccines Digital Biomanufacturing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Vaccines Digital Biomanufacturing Market Size by Country (2020-2025)
5.2 Americas Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
5.3 Americas Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Digital Biomanufacturing Market Size by Region (2020-2025)
6.2 APAC Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
6.3 APAC Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccines Digital Biomanufacturing Market Size by Country (2020-2025)
7.2 Europe Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
7.3 Europe Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccines Digital Biomanufacturing by Region (2020-2025)
8.2 Middle East & Africa Vaccines Digital Biomanufacturing Market Size by Type (2020-2025)
8.3 Middle East & Africa Vaccines Digital Biomanufacturing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vaccines Digital Biomanufacturing Market Forecast
10.1 Global Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
10.1.1 Global Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
10.1.2 Americas Vaccines Digital Biomanufacturing Forecast
10.1.3 APAC Vaccines Digital Biomanufacturing Forecast
10.1.4 Europe Vaccines Digital Biomanufacturing Forecast
10.1.5 Middle East & Africa Vaccines Digital Biomanufacturing Forecast
10.2 Americas Vaccines Digital Biomanufacturing Forecast by Country (2026-2031)
10.2.1 United States Market Vaccines Digital Biomanufacturing Forecast
10.2.2 Canada Market Vaccines Digital Biomanufacturing Forecast
10.2.3 Mexico Market Vaccines Digital Biomanufacturing Forecast
10.2.4 Brazil Market Vaccines Digital Biomanufacturing Forecast
10.3 APAC Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
10.3.1 China Vaccines Digital Biomanufacturing Market Forecast
10.3.2 Japan Market Vaccines Digital Biomanufacturing Forecast
10.3.3 Korea Market Vaccines Digital Biomanufacturing Forecast
10.3.4 Southeast Asia Market Vaccines Digital Biomanufacturing Forecast
10.3.5 India Market Vaccines Digital Biomanufacturing Forecast
10.3.6 Australia Market Vaccines Digital Biomanufacturing Forecast
10.4 Europe Vaccines Digital Biomanufacturing Forecast by Country (2026-2031)
10.4.1 Germany Market Vaccines Digital Biomanufacturing Forecast
10.4.2 France Market Vaccines Digital Biomanufacturing Forecast
10.4.3 UK Market Vaccines Digital Biomanufacturing Forecast
10.4.4 Italy Market Vaccines Digital Biomanufacturing Forecast
10.4.5 Russia Market Vaccines Digital Biomanufacturing Forecast
10.5 Middle East & Africa Vaccines Digital Biomanufacturing Forecast by Region (2026-2031)
10.5.1 Egypt Market Vaccines Digital Biomanufacturing Forecast
10.5.2 South Africa Market Vaccines Digital Biomanufacturing Forecast
10.5.3 Israel Market Vaccines Digital Biomanufacturing Forecast
10.5.4 Turkey Market Vaccines Digital Biomanufacturing Forecast
10.6 Global Vaccines Digital Biomanufacturing Forecast by Type (2026-2031)
10.7 Global Vaccines Digital Biomanufacturing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Vaccines Digital Biomanufacturing Forecast
11 Key Players Analysis
11.1 Cytiva (Danaher Corporation)
11.1.1 Cytiva (Danaher Corporation) Company Information
11.1.2 Cytiva (Danaher Corporation) Vaccines Digital Biomanufacturing Product Offered
11.1.3 Cytiva (Danaher Corporation) Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Cytiva (Danaher Corporation) Main Business Overview
11.1.5 Cytiva (Danaher Corporation) Latest Developments
11.2 Eppendorf SE
11.2.1 Eppendorf SE Company Information
11.2.2 Eppendorf SE Vaccines Digital Biomanufacturing Product Offered
11.2.3 Eppendorf SE Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Eppendorf SE Main Business Overview
11.2.5 Eppendorf SE Latest Developments
11.3 Sartorius AG
11.3.1 Sartorius AG Company Information
11.3.2 Sartorius AG Vaccines Digital Biomanufacturing Product Offered
11.3.3 Sartorius AG Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sartorius AG Main Business Overview
11.3.5 Sartorius AG Latest Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Information
11.4.2 Merck KGaA Vaccines Digital Biomanufacturing Product Offered
11.4.3 Merck KGaA Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Merck KGaA Main Business Overview
11.4.5 Merck KGaA Latest Developments
11.5 Aspen Technology Inc
11.5.1 Aspen Technology Inc Company Information
11.5.2 Aspen Technology Inc Vaccines Digital Biomanufacturing Product Offered
11.5.3 Aspen Technology Inc Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Aspen Technology Inc Main Business Overview
11.5.5 Aspen Technology Inc Latest Developments
11.6 K枚rber AG
11.6.1 K枚rber AG Company Information
11.6.2 K枚rber AG Vaccines Digital Biomanufacturing Product Offered
11.6.3 K枚rber AG Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 K枚rber AG Main Business Overview
11.6.5 K枚rber AG Latest Developments
11.7 AmpleLogic
11.7.1 AmpleLogic Company Information
11.7.2 AmpleLogic Vaccines Digital Biomanufacturing Product Offered
11.7.3 AmpleLogic Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 AmpleLogic Main Business Overview
11.7.5 AmpleLogic Latest Developments
11.8 Siemens
11.8.1 Siemens Company Information
11.8.2 Siemens Vaccines Digital Biomanufacturing Product Offered
11.8.3 Siemens Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Siemens Main Business Overview
11.8.5 Siemens Latest Developments
11.9 Thermo Fisher Scientific Inc.
11.9.1 Thermo Fisher Scientific Inc. Company Information
11.9.2 Thermo Fisher Scientific Inc. Vaccines Digital Biomanufacturing Product Offered
11.9.3 Thermo Fisher Scientific Inc. Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Thermo Fisher Scientific Inc. Main Business Overview
11.9.5 Thermo Fisher Scientific Inc. Latest Developments
11.10 ABB
11.10.1 ABB Company Information
11.10.2 ABB Vaccines Digital Biomanufacturing Product Offered
11.10.3 ABB Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 ABB Main Business Overview
11.10.5 ABB Latest Developments
11.11 Bruker
11.11.1 Bruker Company Information
11.11.2 Bruker Vaccines Digital Biomanufacturing Product Offered
11.11.3 Bruker Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bruker Main Business Overview
11.11.5 Bruker Latest Developments
11.12 Hamilton Company
11.12.1 Hamilton Company Company Information
11.12.2 Hamilton Company Vaccines Digital Biomanufacturing Product Offered
11.12.3 Hamilton Company Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hamilton Company Main Business Overview
11.12.5 Hamilton Company Latest Developments
11.13 Dassault Syst猫mes
11.13.1 Dassault Syst猫mes Company Information
11.13.2 Dassault Syst猫mes Vaccines Digital Biomanufacturing Product Offered
11.13.3 Dassault Syst猫mes Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Dassault Syst猫mes Main Business Overview
11.13.5 Dassault Syst猫mes Latest Developments
11.14 Kymanox Corporation
11.14.1 Kymanox Corporation Company Information
11.14.2 Kymanox Corporation Vaccines Digital Biomanufacturing Product Offered
11.14.3 Kymanox Corporation Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Kymanox Corporation Main Business Overview
11.14.5 Kymanox Corporation Latest Developments
11.15 Invert, Inc.
11.15.1 Invert, Inc. Company Information
11.15.2 Invert, Inc. Vaccines Digital Biomanufacturing Product Offered
11.15.3 Invert, Inc. Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Invert, Inc. Main Business Overview
11.15.5 Invert, Inc. Latest Developments
11.16 Genedata AG
11.16.1 Genedata AG Company Information
11.16.2 Genedata AG Vaccines Digital Biomanufacturing Product Offered
11.16.3 Genedata AG Vaccines Digital Biomanufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Genedata AG Main Business Overview
11.16.5 Genedata AG Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂